Mad Money with Jim Cramer - MAD CAP RECAP - The Official Mad Money Blog
RSS FEED
RECENT POSTS
- Don’t Trust Buybacks
- Buying the Right Sell-Off Stocks
- Buy Broken Stocks, Not Broken Companies
- The Biggest Market Myth There Is?
- The Key to a Successful Turnaround
- Lightning Round: Corning, Visa, NYSE Euronext and More
- Cramer’s 3 Stocks to Avoid
- Cramer: Play Defense with B&G Foods
- Cramer: Chico’s Proves Ailing Retailers Can Make a Comeback
- Cramer's Advice for the SEC
MAD MONEY FEATURES
PODCASTSWatch the Lightning Round whenever and wherever you want.
OFFICIAL MAD MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
CRAMERS SOUNDBOARDAdmit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.
CHECK OUT OUR PHOTOSCheck out Cramer on set, back to school, behind the scenes and more.
SHOP FOR MAD MERCHANDISEBuy Cramer books, bobbleheads and other Mad Money merchandise.
RING TONESPick up the phone! It's Cramer! New Mad Money sounds for your cell phone.
TEXT MESSAGE ALERTMad Money's mobile. Get show highlights sent to your phone.
Cramer's Mea Culpa: Skechers, Cree & Rubicon
Text Size 
Web Editor, Mad Money
Cramer ate crow on Friday as part of his observance of this Day of Atonement. He was coming clean for getting wrong these three stocks: Skechers USA, Cree and Rubicon.
Skechers [SKX
Loading...
()
] he liked as part of the bull market in shoes, a long-term thesis he thought would protect the stock against other short-term concerns. But those concerns stirred up enough investors to sink the company’s share price. After rising to $42.04 on June 17 from $30.26 on March 8, which his when Cramer first recommended it, the stock has since plummeted to $23.22.
Why? Mainly because the company announced it was facing a class-action lawsuit that questioned the validity of the health claims for its Shape-up toning shoes. That and growing worries about lower unit volumes, increased discounting by retailers and rising competition in the toning shoe biz from Nike [NKE
Loading...
()
] and Reebok. Plus, a general sense of fear about the macroeconomic picture over the summer hurt retail as a whole, including Skeckers.
Still, Cramer thinks stock is a buy. The long-term story is still intact, he said, and there’s little downside left in SKX. Plus, according to analysis from Wedbush, even a complete collapse in the toning-shoe category leaves Skechers with $8 of cash per share and growth to spare. And even a puny 10 multiple on this stock puts the share price at $25, a buck higher than its present level. So while Cramer admitted he got this one wrong once, he’s willing to stick with it given these other positives.
Cramer wouldn’t sell Cree [CREE
Loading...
()
] or Rubicon [RBCN
Loading...
()
] at these levels either, but he’s not exactly a buyer of them either. He’d recommended the stocks as plays on the switch from incandescent bulbs to more energy-efficient LED ones. But the specter haunting their performance was exposure to another LED segment, the backlighting screens and mobile phones. Cramer knew these stocks traded on this backlighting business, but thought the bigger theme—green energy—would carry them above it. Not so, apparently, as Cree and Rubicon are down 26% and 18%, respectively, from his initial recommendations.
The play on these stocks then is to wait until the Street recognizes that energy efficiency matters more to earnings than backlighting.
“That’s when we’ll get the bottom,” Cramer said.
Call Cramer: 1-800-743-CNBC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Data is a real-time snapshot *Data is delayed at least 15 minutes
